No, Novartis and Roche won’t merge (yet)!

14/10/2015 - 2 minutes

Novartis already owns 33% of Roche, but even if both companies are headquartered in the same city of Basel (Switzerland), they still have no plans to merge.

Joerg Reinhardt, The Chairman of Novartis – the second biggest Pharma company worldwide by market cap (€212Bn – J&J: €231Bn), was asked about it on the Swiss TV Bilanz Business Talk.

 On paper, you can generate a lot of value, that is true.” He said.

But it makes more sense to him to stay independent. It increases the competition, even if the offices are only located a few kilometers away.

Let’s say it’s more of an artificial competition between two biotechs than a real one, just enough to create a sensation of company identity and belonging. However, the perceived competition is more founded for employees, partners and providers outside Switzerland, who continue to see Roche and Novartis as two entirely different biotech companies.

The research and business strategies of both also differ.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!